Oligonucleotide Synthesis Market by End-users and Geography - Forecast and Analysis 2019-2023

The global oligonucleotide synthesis market has the potential to grow by USD 1.02 billion during 2019-2023, and the market’s growth momentum will accelerate throughout the forecast period.

This report provides a detailed analysis of the market by end-users (pharmaceutical and biotechnology companies, research and academic institutes, diagnostic laboratories, and hospitals) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Agilent Technologies Inc., Danaher Corp., General Electric Co., GenScript Biotech Corp., Kaneka Corp., Merck KGaA, Nitto Denko Corp., QIAGEN NV, Sarepta Therapeutics Inc., and Thermo Fisher Scientific Inc.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of oligonucleotide synthesis market

Request a FREE sample now!

Market Competitive Analysis

The market is currently concentrated, and the degree of concentration will remain the same during the forecast period. To expand their product portfolios, increase their market presence, and gain access to new technologies, many market vendors are adopting inorganic growth strategies such as collaborations and partnerships. Agilent Technologies Inc., Danaher Corp., and General Electric Co. are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, diversity in oligonucleotide molecules will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this oligonucleotide synthesis market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this oligonucleotide synthesis market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading oligonucleotide synthesis companies, including:

• Agilent Technologies Inc.
• Danaher Corp.
• General Electric Co.
• GenScript Biotech Corp.
• Kaneka Corp.
• Merck KGaA
• Nitto Denko Corp.
• QIAGEN NV
• Sarepta Therapeutics, Inc.
• Thermo Fisher Scientific Inc.

Oligonucleotide Synthesis Market: Segmentation by Region

For more insights on the oligonucleotide synthesis market share of various regions Request for a FREE sample now!

The rising prevalence of rare diseases has increased the demand for oligonucleotide therapies in North America. This has compelled many pharmaceutical and biotechnology companies to develop novel therapies using oligonucleotide synthesis technologies.

Nearly 43% of the market growth will originate from North America during the forecast period. The growing approval of oligonucleotide drugs by the US FDA has increased the availability of such therapies in the region. Additionally, the presence of a large number of research institutes has benefitted the growth of oligonucleotide synthesis market size in North America. The US is the critical market for oligonucleotide synthesis in North America. However, the market growth in the region will be slower than the growth of the market in other regions.

Oligonucleotide Synthesis Market: Segmentation by End-users

Request for a FREE sample and Get more information on the market contribution of various end-user segments

Pharmaceutical and biotechnological companies are one of the significant oligonucleotide end-users synthesis products and services, reagents, and equipment. Many pharmaceutical companies are increasing their focus on developing innovative first-in-class products. This has increased the use of oligonucleotide probes and primers for the development of novel pharmaceutical compounds.

Market growth in this end-user segment will be faster than the growth of the market in research and academic institutes and diagnostic laboratories segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the oligonucleotide synthesis market size.

Oligonucleotides Synthesis Market: Key Drivers and Trends

The growing prevalence of chronic and other diseases are compelling many pharmaceutical and biotechnological research companies to increase their efforts to develop effective therapies and diagnostic techniques. Advancements in life science research have improved the understanding of biological systems. Several pharmaceutical and biotechnology researchers are leveraging oligonucleotide synthesis technologies for molecular-level development, design, and modification of biological systems. Oligonucleotides also find many applications in pharmaceutical and biotechnology-based research activities. They are used in recombinant DNA technologies to develop monoclonal antibodies. Many market vendors are partnering with research organizations to support and drive innovations in many such biotechnology researches using oligonucleotides. The increasing research activities in the pharmaceutical and biotechnology sectors is one of the critical factors driving oligonucleotide synthesis market growth during the forecast period.

• There is also an increased focus on the R&D of new oligonucleotide therapeutics.
• Limited availability of approved drugs is encouraging vendors to focus on increasing their R&D efforts to develop novel oligonucleotide drugs for the treatment of many diseases.
• Oligonucleotides efficiently target disease-relevant proteins and genes that are inaccessible by small-molecule drugs and biologic drugs.
• Recent advances have helped overcome challenges associated with the administration, cellular uptake, biodistribution, and side effects of oligonucleotide therapies.
• Currently, almost 140 oligonucleotide therapies are in various stages of clinical trials for the treatment of many diseases, including viral infections, rare genetic disorders, neural and neuromuscular conditions, and cancers.
• During 2019-2023, the market will register a CAGR of more than 10%.

Request for a FREE sample now!

Oligonucleotide Synthesis Market: Key Highlights of the Report for the Forecast Period 2019-2023

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the oligonucleotide synthesis market size during the next five years
• Precise estimation of the global oligonucleotide synthesis market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the oligonucleotide synthesis industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of oligonucleotide synthesis vendors  

We can help! Our analysts can customize this report to meet your requirements. Get in touch